Open AccessA Famous Chinese Prescription That Promotes Hcn4 Activity in Bone Marrow Mesenchymal Stem Cells is Shenfu Injection: Opinion
Author(s) -
Rong Li
Publication year - 2021
Publication title -
hsoa journal of alternative, complementary and integrative medicine
Language(s) - English
Resource type - Journals
ISSN - 2470-7562
DOI - 10.24966/acim-7562/100196
Subject(s) - sss* , medicine , sick sinus syndrome , mesenchymal stem cell , medical prescription , mechanism (biology) , cardiology , therapeutic effect , bioinformatics , pharmacology , pathology , philosophy , epistemology , biology
Sick Sinus Syndrome (SSS) refers to a group of heart rhythm disorders caused by problems relating to the sinus node. Currently, there is no effective treatment for SSS, and an electronic pacemaker is required to support heart function in SSS patients. However, electronic pacemakers are associated with several defects. For example, external magnetic noise commonly interferes, leading to complications. In addition, some patients, especially children with congenitals inoatrial node dysfunction, are not suitable subjects for pacemaker insertion. Therefore, the search for new therapeutic strategies for treating cardiovascular diseases has become imperative. Shenfu injection (SFI), a Chinese herbal medicine, is effective in improving bradyarrhythmia. However, the underlying mechanism of SFI's therapeutic effect remains elusive.